The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Open accessPublished version of a preprint
Abstract
Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment are urgently needed. We generated a pancreatic cancer patient–derived organoid (PDO) library that recapitulates the mutational spectrum and transcriptional subtypes of primary pancreatic cancer. New driver oncogenes were nominated and transcriptomic analyses revealed unique clusters. PDOs exhibited heterogeneous responses to standard-of-care chemotherapeutics and investigational agents. In a case study manner, we found that PDO therapeutic profiles paralleled patient outcomes and that PDOs enabled longitudinal assessment of chemosensitivity and evaluation of synchronous metastases. We derived organoid-based gene expression signatures of chemosensitivity that predicted improved responses for many patients to chemotherapy in both the adjuvant and advanced disease settings. Finally, we nominated alternative treatment strategies for chemorefractory PDOs using targeted agent therapeutic profiling. We propose that combined molecular and therapeutic profiling of PDOs may predict clinical response and enable prospective therapeutic selection. Significance: New approaches to prioritize treatment strategies are urgently needed to improve survival and quality of life for patients with pancreatic cancer. Combined genomic, transcriptomic, and therapeutic profiling of PDOs can identify molecular and functional subtypes of pancreatic cancer, predict therapeutic responses, and facilitate precision medicine for patients with pancreatic cancer. Cancer Discov; 8(9); 1112–29. ©2018 AACR. See related commentary by Collisson, p. 1062. This article is highlighted in the In This Issue feature, p. 1047
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“114 PDO cultures from 101 patients were generated127 and subjected to transcriptomic profiling, followed by therapeutic profiling”
From Human disease models in drug development (2023) · cites this paper as [127]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The treatment outcome of the PDOs positively correlated with individual patient responses”
From Human disease models in drug development (2023) · cites this paper as [127]
The cited source says what the claim attributes to it.
In the citing paper
“patient-derived tumoroid models also show promise in testing drug efficacy and potentially determining a personalized treatment for the patient7–12.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [10]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This heterogeneity in treatment responses is now being exploited for the treatment of cystic fibrosis patients191, with a large ongoing European multicentre clinical trial study, led by the HIT-Cystic Fibrosis consortium, to identify potential responders214.”
From Organoids (2022) · cites this paper as [214]
Experimental — accuracy not yet measuredIn the citing paper
“Recently, normal and tumor organoid models have been developed from both human and mouse pancreas (82, 83).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [83]
In the citing paper
“Furthermore, with recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines), a new generation of cancer cell models is being derived to allow full representation of the histopathological and molecular diversity of tumours (37–42).”
From Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,037
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,001
Evan, T., Wang, V. M.-Y., & Behrens, A. (2022) · Oncogene · doi:10.1038/s41388-022-02448-x · Cited by 66
Organoid Models for Cancer Research
Clevers, H. C., & Tuveson, D. A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055702 · Cited by 69
Self-citationPancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
Juiz, N. A., Iovanna, J., & Dusetti, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00246 · Cited by 63
Stalnecker, C. A., Grover, K. R., Edwards, A. C., Coleman, M. F., Yang, R., DeLiberty, J. M., Papke, B., Goodwin, C. M., Pierobon, M., Petricoin, E. F., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1443 · Cited by 64
Cartry, J., Bedja, S., Boilève, A., Mathieu, J. R. R., Gontran, E., Annereau, M., Job, B., Mouawia, A., Mathias, P., de Baère, T., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02853-4 · Cited by 71
Calandrini, C., van Hooff, S. R., Paassen, I., Ayyildiz, D., Derakhshan, S., Dolman, M. E. M., Langenberg, K. P. S., van de Ven, M., de Heus, C., Liv, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109568 · Cited by 63
Hogenson, T. L., Xie, H., Phillips, W. J., Toruner, M. D., Li, J., Horn, I. P., Kennedy, D. J., Almada, L. L., Marks, D. L., Carr, R. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158060 · Cited by 64
Organoid models of the tumor microenvironment and their applications
Xia, T., Du, W., Chen, X., & Zhang, Y.-N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16578 · Cited by 63
Kirtonia, A., Pandey, A. K., Ramachandran, B., Mishra, D. P., Dawson, D. W., Sethi, G., Ganesan, T. S., Koeffler, H. P., & Garg, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04392-1 · Cited by 61
Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
Pham, T. D., Shields, M. A., Spaulding, C., Principe, D. R., Li, B., Underwood, P. W., Trevino, J. G., Bentrem, D. J., & Munshi, H. G. (2021) · Cancers · doi:10.3390/cancers13030440 · Cited by 64
The frontier of live tissue imaging across space and time
Huang, Q., Garrett, A., Bose, S., Blocker, S. J., Rios, A. C., Clevers, H. C., & Shen, X. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.010 · Cited by 60
Self-citationFarshadi, E. A., Chang, J., Sampadi, B. K., Doukas, M., Land, F. R. V. ‘., van der Sijde, F., Vietsch, E. E., Pothof, J., Koerkamp, B. G., & van Eijck, C. H. J. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1681 · Cited by 60
Engel, R. M., Chan, W. H., Nickless, D. K., Hlavca, S., Richards, E., Kerr, G., Oliva, K., McMurrick, P. J., Jardé, T., & Abud, H. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010128 · Cited by 59
Beato, F., Reverón, D., Dezsi, K. B., Ortiz, A. C., Johnson, J., Chen, D., Ali, K. N., Yoder, S., Jeong, D. K., Malafa, M. P., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00494-1 · Cited by 59
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges
Seyhan, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713340 · Cited by 66
Somerville, T. D. D., Xu, Y., Wu, X., Maia-Silva, D., Hur, S. K., de Almeida, L. M. N., Preall, J. B., Koo, P. K., & Vakoc, C. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921484117 · Cited by 60
Self-citationForsythe, S. D., Sasikumar, S., Moaven, O., Sivakumar, H., Shen, P., Levine, E. A., Söker, S., Skardal, A., & Votanopoulos, K. I. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08790-2 · Cited by 61
Organoids in high-throughput and high-content screenings
Lampart, F. L., Iber, D., & Doumpas, N. (2023) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2023.1120348 · Cited by 61
April-Monn, S., Wiedmer, T., Skowronska, M., Maire, R., Lena, M. S., Trippel, M., Domenico, A. D., Muffatti, F., Andreasi, V., Capurso, G., et al. (2020) · Neuroendocrinology · doi:10.1159/000507669 · Cited by 59
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Regel, I., Mayerle, J. V., & Mukund, M. U. (2020) · Cancers · doi:10.3390/cancers12041024 · Cited by 61
Romano, A., Palumbo, G. A., Parrinello, N. L., Conticello, C., Martello, M., & Terragna, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00699 · Cited by 60
Michl, P., Löhr, M. J., Neoptolemos, J. P., Capurso, G., Rebours, V., Malats, N., Ollivier, M., & Ricciardiello, L. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12123 · Cited by 60
The future of tumor organoids in precision therapy
Kim, S., van de Wetering, M., Clevers, H. C., & Sanders, K. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.03.005 · Cited by 62
Self-citationMaru, Y., Tanaka, N., Ebisawa, K., Odaka, A., Sugiyama, T., Itami, M., & Hippo, Y. (2019) · Cancer Science · doi:10.1111/cas.14119 · Cited by 57
Assay establishment and validation of a high-throughput organoid-based drug screening platform
Li, X., Fu, G., Zhang, L., Guan, R., Tang, P., Zhang, J., Rao, X., Chen, S., Xu, X., Zhou, Y., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02902-3 · Cited by 56
Cancer organoids: A platform in basic and translational research
Ma, X., Wang, Q. L., Li, G., Li, H., Xu, S., & Pang, D. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.052 · Cited by 62
Ren, X., Huang, M., Weng, W., Xie, Y., Wu, Y., Zhu, S., Zhang, Y., Li, D., Lai, J., Shen, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101277 · Cited by 55
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Taurin, S., Alzahrani, R., Aloraibi, S., Ashi, L., AlHarmi, R. A. R., & Hassani, N. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102226 · Cited by 57
Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer
Mavros, M. N., Moris, D., Karanicolas, P. J., Katz, M. H. G., O'Reilly, E. M., & Pawlik, T. M. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0149 · Cited by 55
Progress in Animal Models of Pancreatic Ductal Adenocarcinoma
Kong, K., Guo, M., Liu, Y., & Zheng, J. (2020) · Journal of Cancer · doi:10.7150/jca.37529 · Cited by 57
Derouet, M. F., Allen, J., Wilson, G. W., Ng, C., Radulovich, N., Kalimuthu, S. N., Tsao, M., Darling, G. E., & Yeung, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-71589-4 · Cited by 54
Berg, H. F., Hjelmeland, M. E., Lien, H. E., Espedal, H., Fonnes, T., Srivastava, A., Stokowy, T., Strand, E., Bozickovic, O., Stefansson, I. M., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00019-x · Cited by 59
Granat, L. M., Kambhampati, O., Klosek, S., Niedzwecki, B., Parsa, K., & Zhang, D. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12077 · Cited by 56
Gendoo, D. M. A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.01.010 · Cited by 53
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
Forsythe, S. D., Sivakumar, H., Erali, R. A., Wajih, N., Li, W., Shen, P., Levine, E. A., Miller, K. E., Skardal, A., & Votanopoulos, K. I. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12086-y · Cited by 54
Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors
Chen, C., Li, H.-W., Wang, Y., Lee, C.-C., Shen, Y.-C., Hsieh, C.-Y., Lin, H., Chen, X.-X., Cho, D., Hsieh, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20487-y · Cited by 54
Shu, D., Shen, M., Li, K., Han, X., Li, H., Tan, Z., Wang, Y., Peng, Y., Tang, Z., Qu, C., et al. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2122550 · Cited by 53
Rapid tissue prototyping with micro-organospheres
Wang, Z., Boretto, M., Millen, R., Natesh, N. R., Reckzeh, E. S., Hsu, C., Negrete, M., Yao, H., Quayle, W. B., Heaton, B. E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.016 · Cited by 56
Self-citationIkezawa, K., Urabe, M., Kai, Y., Takada, R., Akita, H., Nagata, S., & Ohkawa, K. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad176 · Cited by 52
Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncology
Dantes, Z., Yen, H.-Y., Pfarr, N., Winter, C., Steiger, K., Muckenhuber, A., Hennig, A., Lange, S., Engleitner, T., Öllinger, R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137809 · Cited by 53
Chakrabarti, J. L., Koh, V., So, J. B. Y., Yong, W. P., & Zavros, Y. L. (2021) · Journal of Visualized Experiments · doi:10.3791/61443 · Cited by 51
Park, M., Kwon, J., Kong, J., Moon, S. M., Cho, S., Yang, K. Y., Jang, W. I., Kim, M., Kim, Y., & Shin, U. S. (2021) · Cancers · doi:10.3390/cancers13153760 · Cited by 54
Next generation organoid engineering to replace animals in cancer drug testing
Hockney, S., Parker, J., Turner, J. E., Todd, X., Todryk, S. M., Gieling, R. G., Hilgen, G., Simoes, D. C. M., & Pal, D. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115586 · Cited by 54
EUS tissue acquisition: From A to B
Kovacevic, B., & Vilmann, P. (2020) · Endoscopic Ultrasound · doi:10.4103/eus.eus_21_20 · Cited by 51
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
Froeling, F. E. M., Casolino, R., Pea, A., Biankin, A. V., Chang, D. K.-F., & Precision-Panc, O. B. O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10010149 · Cited by 52
Self-citationTraub, B., Link, K. H., & Kornmann, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.030 · Cited by 51
Tsai, K. K., Huang, S., Northey, J. J., Liao, W., Hsu, C., Cheng, L., Werner, M. E., Chuu, C., Chatterjee, C., Lakins, J. N., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00375-0 · Cited by 53
Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
Sondorp, L. H. J., Ogundipe, V. M. L., Groen, A. H., Kelder, W., Kemper, A., Links, T. P., Coppes, R. P., & Kruijff, S. (2020) · Cancers · doi:10.3390/cancers12113212 · Cited by 51
Gastrointestinal cancer organoids—applications in basic and translational cancer research
Seidlitz, T., & Stange, D. E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00654-3 · Cited by 52
Chen, D., Su, X., Zhu, L., Hao, J., Han, B., Chen, H., Liang, Q., Hu, C., Yang, H., Liu, L., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03848-z · Cited by 50
Aldea, M. D., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J., Nikolaev, S. I., & André, F. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101642 · Cited by 52
Precision models in hepatocellular carcinoma
Bárcena‐Varela, M., Monga, S. P., & Lujambio, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01024-w · Cited by 57
Biobanking of human gut organoids for translational research
Perrone, F. M., & Zilbauer, M. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00606-x · Cited by 54
Jose, A., Kulkarni, P., Thilakan, J., Munisamy, M., Malhotra, A. G., Singh, J., Kumar, A., Rangnekar, V. M., Arya, N., & Rao, M. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01916-6 · Cited by 49
Frappart, P., & Hofmann, T. G. (2020) · Cancers · doi:10.3390/cancers12102750 · Cited by 48
Lin, J.-C., Liu, T.-P., & Yang, P.-M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124019 · Cited by 46
Vaes, R. D. W., van Dijk, D. P. J., Welbers, T. T. J., Blok, M. J., Aberle, M. R., Heij, L. R., Boj, S. F., Damink, S. W. M. O., & Rensen, S. S. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12627 · Cited by 48
Glioblastoma modeling with 3D organoids: progress and challenges
Wang, X., Sun, Y., Zhang, D. Y., Ming, G.-L., & Song, H. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad008 · Cited by 46
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Veith, I., Nurmik, M., Mencattini, A., Damei, I., Lansche, C., Brosseau, S., Gropplero, G., Corgnac, S., Filippi, J., Poté, N., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101549 · Cited by 49
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 56
A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
Price, S., Bhosle, S. G., Gonçalves, E., Li, X., McClurg, D. P., Barthorpe, S., Beck, A., Hall, C., Lightfoot, H. W., Farrow, L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09508-y · Cited by 47
Living biobank-based cancer organoids: prospects and challenges in cancer research
Li, H., Liu, H., & Chen, K. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0621 · Cited by 50
A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
Garajová, I., Peroni, M., Gelsomino, F., & Leonardi, F. (2023) · Current Oncology · doi:10.3390/curroncol30110694 · Cited by 48
Choi, S. Y., Jeon, A.-R., Kim, M. K., Lee, Y., Im, J.-E., Koh, J.-W., Han, S., Kong, S., Yoon, K., Koh, Y. H., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00875 · Cited by 45
Clark, C., Yoo, K. M., Sivakumar, H., Strumpf, K., Laxton, A. W., Tatter, S. B., Strowd, R. E., III, & Skardal, A. (2022) · Biomedical Materials · doi:10.1088/1748-605x/aca05d · Cited by 48
Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids
Skala, M. C., Deming, D. A., & Kratz, J. D. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110220-123503 · Cited by 46
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 48
Self-citationPatient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing
Zu, M., Hao, X., Ning, J., Zhou, X., Gong, Y., Lang, Y., Xu, W., Zhang, J., & Ding, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114751 · Cited by 44
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 48
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 45
Novelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059579 · Cited by 43
Ivanova, E. V., Kuraguchi, M., Xu, M., Portell, A. J., Taus, L. J., Diala, I., Lalani, A. S., Choi, J., Chambers, E. S., Li, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1844 · Cited by 45
Yu, Y., Yang, G., Huang, H., Fu, Z., Cao, Z., Zheng, L., You, L., & Zhang, T. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01787-5 · Cited by 42
Klomp, J. E., Lee, Y. S., Goodwin, C. M., Papke, B., Klomp, J. A., Waters, A. M., Stalnecker, C. A., DeLiberty, J. M., Drizyte‐Miller, K., Yang, R. Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110060 · Cited by 44
Foglizzo, V., Cocco, E., & Marchiò, S. (2022) · Cancers · doi:10.3390/cancers14153692 · Cited by 48
Li, J., Xu, H., Zhang, L., Song, L., Feng, D., Peng, X., Wu, M., Zou, Y., Wang, B., Zhan, L., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03004-z · Cited by 48
Self-citationCharacteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review
van der Beek, J. N., Geller, J. I., de Krijger, R. R., Graf, N. M., Pritchard‐Jones, K., Drost, J., Verschuur, A. C., Murphy, D., Ray, S., Spreafico, F., et al. (2020) · Cancers · doi:10.3390/cancers12071776 · Cited by 42
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Hennig, A., Baenke, F., Klimová, A., Drukewitz, S., Jahnke, B., Brückmann, S., Secci, R., Winter, C., Schmäche, T., Seidlitz, T., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5906 · Cited by 42
Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02301-9 · Cited by 41
Xing, F., Liu, Y., Huang, S., Lyu, X., Su, S. M., Chan, U. I., Wu, P., Yan, Y., Ai, N., Li, J., et al. (2021) · Theranostics · doi:10.7150/thno.59533 · Cited by 41
Pancreatic cancer environment: from patient-derived models to single-cell omics
Gu, A., Li, J., Qiu, S., Hao, S., Yue, Z., Zhai, S., Li, M., & Liu, Y. (2024) · Molecular Omics · doi:10.1039/d3mo00250k · Cited by 41
Advancing cancer research through organoid technology
Zeng, G., Yu, Y., Wang, M., Liu, J., He, G., Yu, S., Yan, H., Yang, L., Li, H., & Peng, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05824-1 · Cited by 43
Knox, J. J., O'Kane, G. M., King, D. A., Laheru, D. A., Habowski, A. N., Yu, K. H., Perez, K. J., Aguirre, A. J., Coyne, Z. L., Harvey, H. M., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-00436 · Cited by 41
Self-citationPatzak, M. S., Kari, V., Patil, S., Hamdan, F. H., Goetze, R. G., Brunner, M., Gaedcke, J., Kitz, J., Jodrell, D. I., Richards, F. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.037 · Cited by 41
Ntafoulis, I., Kleijn, A., Ju, J., Jimenez-Cowell, K., Fabro, F., Klein, M., Yen, R. T. C., Balvers, R. K., Li, Y., Stubbs, A., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02402-y · Cited by 40
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Antal, C. E., Oh, T. G., Aigner, S., Luo, E., Yee, B. A., Campos, T., Tiriac, H., Rothamel, K. L., Zhang, C., Jiao, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40798-6 · Cited by 40
Self-citationVivarelli, S., Candido, S., Caruso, G., Falzone, L., & Libra, M. (2020) · Cancers · doi:10.3390/cancers12123636 · Cited by 41
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma
Habib, J. R., Kinny‐Köster, B., Bou‐Samra, P., Alsaad, R., Sereni, E., Javed, A. A., Ding, D., Cameron, J. L., Lafaro, K. J., Burns, W. R., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004915 · Cited by 40
Self-citationLung cancer organoids, a promising model still with long way to go
Ma, H., Zhu, Y.-J., Zhou, R., Yu, Y., Xiao, Z., & Zhang, H.-B. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103610 · Cited by 41
Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
Turpin, A., Neuzillet, C., Colle, E., Dusetti, N., Nicolle, R., Cros, J. F., de Mestier, L., Bachet, J., & Hammel, P. R. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221118019 · Cited by 41
Fraunhoffer, N. A., Hammel, P. R., Conroy, T., Nicolle, R., Bachet, J., Harlé, A., Rebours, V., Turpin, A., Abdelghani, M. B., Mitry, E., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.06.010 · Cited by 43
Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
Pompella, L., Tirino, G., Pappalardo, A., Caterino, M., Ventriglia, A., Nacca, V., Orditura, M., Ciardiello, F., & Vita, F. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082814 · Cited by 40
Perkail, S., Andricovich, J., Yan, K., & Tzatsos, A. (2020) · Nature Communications · doi:10.1038/s41467-020-16589-8 · Cited by 41
Patient-Derived Cancer Organoids for Precision Oncology Treatment
Pernik, M. N., Bird, C. E., Traylor, J. I., Shi, D. D., Richardson, T. E., McBrayer, S. K., & Abdullah, K. G. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050423 · Cited by 46
Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy
Wu, W., Li, X., & Yu, S. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.050 · Cited by 40
Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic
Long, Y., Xie, B., Shen, H. C., & Wen, D. (2022) · Cells · doi:10.3390/cells11233868 · Cited by 43
Lee, T. W., Lai, A., Harms, J. K., Singleton, D. C., Dickson, B. D., Macann, A., Hay, M. P., & Jamieson, S. M. F. (2020) · Cancers · doi:10.3390/cancers12123743 · Cited by 38
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
Dijkstra, K. K., van den Berg, J. G., Weeber, F., van de Haar, J., Velds, A., Kaing, S., Peters, D. D. G. C., Eskens, F. A. L. M., de Groot, D. J., Tesselaar, M. E. T., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627819 · Cited by 42
Stockslager, M. A., Malinowski, S. W., Touat, M., Yoon, J. C., Geduldig, J. E., Mirza, M., Kim, A. S., Wen, P. Y., Chow, K.-H., Ligon, K. L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109788 · Cited by 36
Metadata
- Authors
- Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M., Patel, H., Ma, M., LaComb, J. F., Palmaira, R. L. D., Javed, A. A., Huynh, J. C., Johnson, M., Arora, K., Robine, N., Shah, M., Sanghvi, R., Goetz, A. B., Lowder, C. Y., Martello, L., Driehuis, E., LeComte, N., Askan, G., Iacobuzio-Donahue, C. A., Clevers, H., Wood, L. D., Hruban, R. H., Thompson, E., Aguirre, A. J., Wolpin, B. M., Sasson, A., Kim, J., Wu, M., Bucobo, J. C., Allen, P., Sejpal, D. V., Nealon, W., Sullivan, J. D., Winter, J. M., Gimotty, P. A., Grem, J. L., DiMaio, D. J., Buscaglia, J. M., Grandgenett, P. M., Brody, J. R., Hollingsworth, M. A., O'Kane, G. M., Notta, F., Kim, E., Crawford, J. M., Devoe, C., Ocean, A., Wolfgang, C. L., Yu, K. H., Li, E., Vakoc, C. R., Hubert, B., Fischer, S. E., Wilson, J. M., Moffitt, R., Knox, J., Krasnitz, A., Gallinger, S., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Johns Hopkins University (US)
- Ontario Institute for Cancer Research (CA)
- Stony Brook University (US)
- Memorial Sloan Kettering Cancer Center (US)
- UC Davis Comprehensive Cancer Center (US)
- New York Genome Center (US)
- Thomas Jefferson University (US)
- SUNY Downstate Health Sciences University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- 6Memorial Sloan Kettering Cancer Center, New York, New York.
- Broad Institute (US)
- Hofstra University (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- University of Pennsylvania (US)
- University of Nebraska Medical Center (US)
- Nebraska Medical Center (US)
- University Health Network (CA)
- Weill Cornell Medicine (US)
- 3PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
- Corresponding author
- Tuveson, David A.
- ORCID
- Tiriac, Hervé
- Engle, Dannielle D.
- Plenker, Dennis
- Deschênes, Astrid
- Somerville, Tim D. D.
- Froeling, Fieke E. M.
- Burkhart, Richard A.
- Denroche, Robert E.
- Jang, Gun-Ho
- Miyabayashi, Koji
- Young, C. Megan
- LaComb, Joseph F.
- Javed, Ammar A.
- Huynh, Jasmine C.
- Johnson, Molly
- Arora, Kanika
- Robine, Nicolas
- Sanghvi, Rashesh
- Lowder, Cinthya Y.
- Martello, Laura
- Driehuis, Else
- LeComte, Nicolas
- Clevers, Hans
- Wood, Laura D.
- Hruban, Ralph H.
- Aguirre, Andrew J.
- Wolpin, Brian M.
- Kim, Joseph
- Wu, Maoxin
- Bucobo, Juan Carlos
- Nealon, William
- Winter, Jordan M.
- Gimotty, Phyllis A.
- Grem, Jean L.
- DiMaio, Dominick J.
- Buscaglia, Jonathan M.
- Grandgenett, Paul M.
- Brody, Jonathan R.
- Hollingsworth, Michael A.
- O'Kane, Grainne M.
- Notta, Faiyaz
- Kim, Edward
- Crawford, James M.
- Devoe, Craig
- Ocean, Allyson
- Wolfgang, Christopher L.
- Yu, Kenneth H.
- Li, Ellen
- Vakoc, Christopher R.
- Fischer, Sandra E.
- Wilson, Julie M.
- Moffitt, Richard
- Knox, Jennifer
- Krasnitz, Alexander
- Tuveson, David A.
- Venue
- Cancer Discovery
- Published
- 2018-09-01
- Volume
- 8
- Issue
- 9
- Pages
- 1112-1129
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6125219
- OpenAlex
- W2807088563
- Cited by
- 1,092
- References
- 62
- Citations by year
- 2026: 132 · 2025: 135 · 2024: 147 · 2023: 130 · 2022: 150 · 2021: 168 · 2020: 128 · 2019: 83 · 2018: 16
- FWCI
- 36.76
- Type
- journal article
- Language
- en
- Open access
- green
- pure.knaw.nl
- Licence
- other-oa
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- HHS | National Institutes of Health (NIH) (5P30CA45508-29, 5P50CA101955-07, P20CA192996-03, 1U10CA180944-04, 5U01CA168409-5, 1R01CA188134-01, 1R01CA190092-04, HHSN26100008)
- Lustgarten Foundation
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic cancer, patient-derived organoids, chemotherapy response, chemotherapy response prediction, predictive biomarkers, transcriptomic subtypes, cancer driver genes, gene expression signatures, synchronous metastases, chemotherapy-refractory disease, targeted therapy, precision medicine, adjuvant chemotherapy
- MeSH terms
- Antineoplastic Agents, Drug Screening Assays, Antitumor, Humans, Organoids, Pancreatic Neoplasms, Prospective Studies, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Gene Regulatory Networks, Precision Medicine, Molecular Targeted Therapy, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
